Skip to main content
Home > Week in Review > Offerings

Chronological Index of : Financial News

 Current Issue
  • Fulgent amends IPO

    Fulgent Genetics Inc., Temple City, Calif. Business: Diagnostic, Supply/Service Date announced: 2016-09-19 Type: IPO To be raised: Up to $64.4 million Shares: 4.6 million Price: $12-$14 Underwriters: Credit Suisse; …

    Published on 9/26/2016
  • Siga amends rights offering

    Siga Technologies Inc. (NASDAQ:SIGA), New York, N.Y. Business: Infectious Date announced: 2016-09-20 Type: Rights offering To be raised: Up to $35.3 million Shares: TBD Price prior: $0.99 Shares outstanding prior: 54.2 …

    Published on 9/26/2016
  • AC Immune completes IPO

    AC Immune S.A. (NASDAQ:ACIU), Lausanne, Switzerland Business: Neurology Date completed: 2016-09-22 Type: IPO Raised: $66 million Shares: 6 million Price: $11 Shares after offering: 55.4 million Underwriters: Credit …

    Published on 9/26/2016
  • Adgero completes venture financing

    Adgero Biopharmaceuticals Inc., Princeton, N.J. Business: Cancer Date completed: 2016-09-16 Type: Venture financing Raised: $9.7 million Placement agent: Aegis Capital

    Published on 9/26/2016
  • Aquinox completes follow-on

    Aquinox Pharmaceuticals Inc. (NASDAQ:AQXP), Vancouver, B.C. Business: Genitourinary, Inflammation, Pulmonary Date completed: 2016-09-19 Type: Follow-on Raised: $75.4 million Shares: 6.2 million Price: $12.25 Shares …

    Published on 9/26/2016
  • Artios completes venture financing

    Artios Pharma Ltd., Cambridge, U.K. Business: Cancer Date completed: 2016-09-21 Type: Venture financing Raised: $33.2 million Investors: SV Life Sciences; Merck Ventures B.V.; Imperial Innovations Group plc; Arix …

    Published on 9/26/2016
  • AurKa completes venture financing

    AurKa Pharma Inc., Montreal, Quebec Business: Cancer Date completed: 2016-09-19 Type: Venture financing Raised: $14.5 million Investor: TVM Life Science Ventures

    Published on 9/26/2016
  • CareDx completes follow-on

    CareDx Inc. (NASDAQ:CDNA), Brisbane, Calif. Business: Diagnostic Date completed: 2016-09-21 Type: Follow-on Raised: $9 million Shares: 2.3 million Price: $4 Shares after offering: 21.2 million Underwriter: Piper Jaffray…

    Published on 9/26/2016
  • Cellenkos completes venture financing

    Cellenkos Inc., Houston, Texas Business: Gene/Cell therapy, Autoimmune Date completed: 2016-09-18 Type: Venture financing Raised: $10 million Investors: Golden Meditech Holdings Ltd.; and an undisclosed investor

    Published on 9/26/2016
  • Faron Pharmaceuticals completes placing

    Faron Pharmaceuticals Oy (LSE:FARN), Turku, Finland Business: Pulmonary, Cancer, Cardiovascular Date completed: 2016-09-21 Type: Placing Raised: L7.2 million ($9.4 million) Shares: 2.9 million Price: 250p Shares after …

    Published on 9/26/2016
  • Faron Pharmaceuticals completes private placement

    Faron Pharmaceuticals Oy (LSE:FARN), Turku, Finland Business: Pulmonary, Cancer, Cardiovascular Date completed: 2016-09-21 Type: Private placement Raised: L830,000 ($1.1 million) Shares: 332,000 Price: 250p Shares after…

    Published on 9/26/2016
  • Histogenics completes private placement of convertible preferred and common stock

    Histogenics Corp. (NASDAQ:HSGX), Waltham, Mass. Business: Musculoskeletal Date completed: 2016-09-16 Type: Private placement of convertible preferred and common stock Raised: $30.1 million Shares: 2.7 million Price: $2.…

    Published on 9/26/2016
  • iOmx completes venture financing

    iOmx Therapeutics AG, Martinsried, Germany Business: Cancer Date completed: 2016-09-22 Type: Venture financing Raised: EUR40 million ($44.6 million) Investors: MPM Capital; Sofinnova Partners; Wellington Partners; Merck…

    Published on 9/26/2016
  • Milo Biotechnology completes venture financing

    Milo Biotechnology LLC, Cleveland, Ohio Business: Musculoskeletal Date completed: 2016-09-20 Type: Venture financing Raised: Not disclosed Investors: JumpStart Inc.; Rev1 Ventures Note: The amount raised is not …

    Published on 9/26/2016
  • Nanobiotix completes debt financing

    Nanobiotix S.A. (Euronext:NANO), Paris, France Business: Cancer Date completed: 2016-09-19 Type: Debt financing Raised: EUR2 million ($2.2 million) Investor: Bpifrance Note: The interest-free loan is due September 2019.

    Published on 9/26/2016
  • NeuroTherapia completes venture financing

    NeuroTherapia Inc., Cleveland, Ohio Business: Neurology Date completed: 2016-09-21 Type: Venture financing Raised: $1.7 million Investor: Alzheimers Drug Discovery Foundation

    Published on 9/26/2016
  • Novan completes IPO

    Novan Inc. (NASDAQ:NOVN), Durham, N.C. Business: Dermatology, Infectious Date completed: 2016-09-20 Type: IPO Raised: $45.1 million Shares: 4.1 million Price: $11 Shares after offering: 15.3 million Underwriters: Piper …

    Published on 9/26/2016
  • Roka completes private placement of convertible preferred stock and warrants

    Roka Bioscience Inc. (NASDAQ:ROKA), Warren, N.J. Business: Diagnostic Date completed: 2016-09-16 Type: Private placement of convertible preferred stock and warrants Raised: $22.5 million Shares: 22,500 Price: $1,000 …

    Published on 9/26/2016
  • Sarepta Therapeutics completes follow-on

    Sarepta Therapeutics Inc. (NASDAQ:SRPT), Cambridge, Mass. Business: Musculoskeletal, Infectious Date completed: 2016-09-22 Type: Follow-on Raised: $299.9 million Shares: 5 million Price: $59.75 Shares after offering: 52…

    Published on 9/26/2016
  • Shire completes private placement of senior notes

    Shire plc (LSE:SHP; NASDAQ:SHPG), Dublin, Ireland Business: Neurology, Gastrointestinal, Endocrine/Metabolic Date completed: 2016-09-19 Type: Private placement of senior notes Raised: $12.1 billion Underwriters: BofA …

    Published on 9/26/2016
  • T2 Biosystems completes private placement

    T2 Biosystems Inc. (NASDAQ:TTOO), Lexington, Mass. Business: Diagnostic Date completed: 2016-09-22 Type: Private placement Raised: $39.7 million Shares: 6.1 million Price: $6.56 Shares after offering: 30.4 million …

    Published on 9/26/2016
  • TenNor Therapeutics completes venture financing

    TenNor Therapeutics Ltd., Suzhou, China Business: Infectious Date completed: 2016-09-19 Type: Venture financing Raised: $25 million Investors: Northern Light Venture Capital; Frontline BioVentures; WuXi Healthcare …

    Published on 9/26/2016
  • Agios financial update

    Agios Pharmaceuticals Inc. (NASDAQ:AGIO), Cambridge, Mass. Business: Cancer, Endocrine/Metabolic Date announced: 2016-09-20 Note: Agios raised $22.5 million through the sale of 505,617 shares at $44.50 to cover the …

    Published on 9/26/2016
  • Capricor Therapeutics financial update

    Capricor Therapeutics Inc. (NASDAQ:CAPR), Beverly Hills, Calif. Business: Cardiovascular Date announced: 2016-09-21 Note: Capricor raised $1.3 million through the sale of 403,125 shares at $3.20 to cover the …

    Published on 9/26/2016
  • Aytu proposes follow-on

    Aytu BioScience Inc. (OTCQX:AYTU), Englewood, Colo. Business: Genitourinary Date announced: 2016-09-21 Type: Follow-on To be raised: Up to $14.4 million Shares: TBD Price prior: $3.50 Underwriters: Joseph Gunnar; Feltl;…

    Published on 9/26/2016

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993